Shaping the Future of Non-Invasive Healing
Our tVNS® devices are the only approved non-invasive vagus nerve stimulation (VNS) devices under the EU Medical Device Regulation (MDR).
Experience a medication-free, low side-effect, non-invasive treatment with tVNS®. Thousands of patients have rediscovered freedom and well-being.
Now it’s your turn.
Remarkable Improvement
in Adolescent Depression
A 17-year-old girl suffering from treatment-resistant depression had expressed intent to die by suicide after high school graduation. Despite years of psychotherapy and medication, her condition remained severe.
After starting Transcutaneous Vagus Nerve Stimulation (tVNS®), she experienced significant improvements. Her depression severity decreased, she graduated from high school, secured a part-time job, and enrolled in university. Both self-reported and clinician- assessed measures showed a reduction in depressive symptoms.
This case highlights the potential of tVNS® as a life-changing treatment for adolescents facing severe, treatment-resistant depression.

Try tVNS® E for
180 Days Now
Patients in Germany and Austria now have the opportunity to try tVNS® E for 180 days for just 1.500,00€[1].
After 180 days, you can choose whether to keep the device and pay the remaining balance, or return the device.
1. Price in Germany is 1.500,00€ including 19% German VAT. Price in Austria is 1.512,61€ including 20% Austrian VAT.

Introducing the tVNS® Triggerbox
Launching December 1, 2024, the tVNS® Triggerbox advances neuromodulation research by providing a cable-bound system that minimizes latencies and enhances protocol reproducibility. This key advancement ensures precise, reliable experimental setups for cutting-edge studies.

Better days are ahead.
Certified Medical Device
Non-Invasive Approach
Control at Your Fingertips
Most Effective Stimulation Site
Why We Lead in Vagus Nerve Stimulation
For over 20 years, our commitment to innovation has positioned us at the forefront of non-invasive vagus nerve stimulation.
Our unmatched research and development efforts are backed by solid clinical trials, ensuring our devices are not only effective but also safe and reliable. As an approved Class IIa medical device under the EU-MDR, we offer scientifically validated solutions in a market crowded with unverified alternatives.
Since introducing the Cerbomed Nemos device, we’ve led the market in non-invasive vagus nerve technology. Our pioneering approach and sustained innovation keep us ahead, with our devices being preferred by healthcare professionals and researchers worldwide due to unmatched safety, reliability and precision.
Developed and manufactured in Germany, our devices meet the highest quality standards, reflecting our dedication to excellence and the well-being of our patients.
Our Devices are Trusted by
Leading Institutions Worldwide
Non-invasive vagus nerve stimulation for the treatment of neurological, mental and physical conditions.
Navigating the world of medical treatments can be overwhelming, especially when faced with persistent and challenging health issues. Whether you’ve been tirelessly seeking effective solutions, or if traditional drug therapies have been unsuccessful, there is another option: tVNS®.
The vagus nerve, central to our body’s nervous system, plays a critical role in maintaining homeostasis. tVNS®, or Transcutaneous Vagus Nerve Stimulation, harnesses the therapeutic potential of this nerve through targeted stimulation of its auricular branch, accessible within the ear.
This innovative approach utilizes gentle electrical impulses to modulate the vagus nerve’s activity, encouraging a state of balance across the body’s systems. The result? A reduction in the symptoms of neurological diseases associated with sympathovagal imbalance, achieved through a method that avoids the invasiveness of surgery and the side effects associated with medication. Approved as a Class IIa medical device under the European Medical Device Regulation (MDR), tVNS® sets a new standard in the treatment of neurological conditions, offering a blend of efficacy, safety, and simplicity.
tVNS® is indicated to treat the following conditions:
- Anxiety
- Atrial Fibrillation
- Autism
- Cognitive Impairment
- Depression
- Epilepsy
- Inflammatory Bowel Syndrome
- Irritable Bowel Disease
- Migraines
- Parkinson's Disease
- Prader-Willi-Syndrome
- Sleep Disorders
- Systemic Sclerosis
- Tinnitus
- Anxiety
- Atrial Fibrillation
- Autism
- Cognitive Impairment
- Depression
- Epilepsy
- Inflammatory Bowel Disease
- Irritable Bowel Syndrome
- Migraines
- Parkinson's Disease
- Prader-Willi-Syndrome
- Sleep Disorders
- Systemic Sclerosis
- Tinnitus

You can use tVNS® anytime, anywhere. It's easy to use, portable, and discrete.
Treatment with tVNS® is characterized by its simplicity and adaptability to everyday life. At its core, tVNS® operates on the principle of neurostimulation, a process that engages the vagus nerve’s capacity to influence various bodily functions and systems. tVNS® stimulates the auricular branch of the vagus nerve (ABVN) through the skin with gentle and precise electrical impulses that propagate therapeutic signals to the brain, first to the brain stem and then to higher centers, aiming to correct dysregulation within the nervous system.
The application of tVNS® is designed with the patient in mind: it is easy, portable, and discreet, making it possible to incorporate treatment sessions into your schedule without interruption to your daily tasks. Whether you’re at home, in the office, or traveling, tVNS® provides a consistent and accessible means to manage symptoms of neurological disorders, including the reduction of seizure frequencies in epilepsy, among other conditions.
Each session with the tVNS® device is a step towards rebalancing the nervous system, leveraging the natural pathways of the body to foster healing and symptom relief. The device’s ease of use ensures that starting and maintaining a regimen with tVNS® is straightforward, empowering users to take control of their health in a non-intrusive, effective manner.
Track, monitor and share your treatment
The innovative tVNS® Patient App is a wellness and session-diary application designed to help users keep a record of their well-being and the duration of their stimulation sessions.
The tVNS® Patient App is available now in the Google Play Store and in the Apple App Store (EU-only).
tVNS® Patient is fully compliant with the General Data Protection Regulation (GDPR), ensuring that patient data is handled with the utmost care and confidentiality.